On January 23, 2024, DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction. The transaction has been approved by Shangai Stock exchange.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.12 CNY | -2.60% | -7.48% | -47.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.31% | 2.06B | |
-55.96% | 9.93B | |
-44.50% | 9.29B | |
-23.82% | 6.82B | |
-2.08% | 6.45B | |
+92.40% | 5.26B | |
-2.63% | 4.62B | |
+5.79% | 4.56B | |
-31.67% | 3.81B | |
+4.94% | 3.06B |
- Stock Market
- Equities
- 603233 Stock
- News DaShenLin Pharmaceutical Group Co., Ltd.
- DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction announced on January 19, 2023